Many Locations

Multiple Locations

1 studies enrolling now · 2 studies all time

What they study most

Children, Chronic Kidney Disease, Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion, Proteinuria

Studies at this site

• Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body — Recruiting now
• A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria — Recruiting now